Leung TW - Search Results

1

The cost of palliative care for hepatocellular carcinoma in Hong Kong.

Chan AT, Jacobs P, Yeo W, Lai M, Hazlett CB, Mok TS, Leung TW, Lau WY, Johnson PJ. Chan AT, et al. Among authors: leung tw. Pharmacoeconomics. 2001;19(9):947-53. doi: 10.2165/00019053-200119090-00006. Pharmacoeconomics. 2001. PMID: 11700781

2

Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

Ho S, Cheng P, Yuen J, Chan A, Leung N, Yeo W, Leung T, Lau WY, Li AK, Johnson PJ. Ho S, et al. Br J Cancer. 1996 Apr;73(8):985-8. doi: 10.1038/bjc.1996.192. Br J Cancer. 1996. PMID: 8611436 Free PMC article.

3

Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.

Wong IH, Lau WY, Leung T, Yeo W, Johnson PJ. Wong IH, et al. Clin Cancer Res. 1999 Dec;5(12):4021-7. Clin Cancer Res. 1999. PMID: 10632334

4

Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.

Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B. Yeo W, et al. Ann Oncol. 2006 Jul;17(7):1083-9. doi: 10.1093/annonc/mdl065. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600982 Free article.

5

Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?

Leung NW, Tam JS, Lai JY, Leung TW, Lau WY, Shiu W, Li AK. Leung NW, et al. Among authors: leung tw. Cancer. 1992 Jul 1;70(1):40-4. doi: 10.1002/1097-0142(19920701)70:1<40::aid-cncr2820700107>3.0.co;2-p. Cancer. 1992. PMID: 1318777

6

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.

Mok TS, Leung TW, Lee SD, Chao Y, Chan AT, Huang A, Lui MC, Yeo W, Chak K, Johnston A, Johnson P. Mok TS, et al. Among authors: leung tw. Cancer Chemother Pharmacol. 1999;44(4):307-11. doi: 10.1007/s002800050982. Cancer Chemother Pharmacol. 1999. PMID: 10447578 Clinical Trial.

7

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.

Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P. Mok TS, et al. Among authors: leung tw. Cancer. 2001 Jun 15;91(12):2369-77. Cancer. 2001. PMID: 11413527

8

Systemic therapy for hepatocellular carcinoma.

Leung TW, Johnson PJ. Leung TW, et al. Semin Oncol. 2001 Oct;28(5):514-20. doi: 10.1016/s0093-7754(01)90144-7. Semin Oncol. 2001. PMID: 11685744 Review.

9

Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.

Poon TC, Chan AT, Zee B, Ho SK, Mok TS, Leung TW, Johnson PJ. Poon TC, et al. Among authors: leung tw. Oncology. 2001;61(4):275-83. doi: 10.1159/000055334. Oncology. 2001. PMID: 11721174

10

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.

Yeo W, Lam KC, Zee B, Chan PS, Mo FK, Ho WM, Wong WL, Leung TW, Chan AT, Ma B, Mok TS, Johnson PJ. Yeo W, et al. Among authors: leung tw. Ann Oncol. 2004 Nov;15(11):1661-6. doi: 10.1093/annonc/mdh430. Ann Oncol. 2004. PMID: 15520068 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters